Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

News

Article

December 15, 2023

Depression, Parenting Stress in Mothers Not Related to Breast Cancer

Author(s):

Ashley Chan

Results from a study found that child-related factors and depression in mothers with breast cancer were not related to cancer.

breast cancer image

In parents with breast cancer, researchers have determined that child-related factors and depression were not related to breast cancer, and that tailored counseling and support are both necessary.

In a study published on JAMA Network Open, 699 women with stages 0 to 3 breast cancer were evaluated to see if having breast cancer affected mental health, such as depression, and parenting stress.

Of the 699 women included in the study, 499 patients were parents, of which 409 patients gave birth before receiving their diagnosis and nine patients gave birth after. The median age of patients without children was 37.3 years, whereas the median age for patients with children was 40.5 years.

The study authors determined that among patients with children, parenting stress was associated with depression. Factors related to stress included age, temperament, emotional problems and patterns of sleep, according to the study. After the researchers analyzed and compared parenting stress to breast cancer, they found that there was no direct correlation.

However, study authors determined that patients with children, who had a high school educational level and received gonadotropin-releasing hormone treatment (which decreases the amount of certain hormones in the body) had an increased risk of depression.

“Among cancer-related factors, disease duration and (gonadotropin-releasing hormone) treatment were associated with maternal depression,” the study authors wrote. “Other cancer-related factors, such as breast cancer stage, BRCA1and BRCA2sequence variation and other treatment modalities, were not associated with depression, which is consistent with the findings of previous studies investigating the association between depression and breast cancer.”

The study authors also noted that although studies in the past have analyzed chemotherapy and its effect on the mind, this study focused on the mental effects gonadotropin-releasing hormone treatment had on patients with breast cancer.

“We found that (gonadotropin-releasing hormone) treatment alone increased the risk of depression in patients who had not undergone chemotherapy,” the study authors wrote. “In general, patients are educated and prepared for chemotherapy prior to treatment, particularly regarding its (potentially) toxic effects; however, such preparation is not common for endocrine therapy.”

READ MORE: Mother With Stage 4 Breast Cancer and Her Family ‘Focus on the Living’

When the study authors analyzed maternal parenting stress regarding caregiver status and child behavioral problems, they found that it was not associated with factors regarding cancer. They noted that mothers with breast cancer who were the main caregivers for their children had higher levels of parenting stress, compared with mothers who had other family members help with caregiving.

“Results of the present study indicated that parenting stress may be more likely to be affected by child-related factors rather than cancer- or treatment-related factors. Thus, when treating mothers with breast cancer, (doctors) should pay attention to the children’s mental health and parenting conditions,” the authors wrote in the study.

The study authors also focused on the emotional development of children with parents who have breast cancer. Similar to their previous findings, they reported that there was “no remarkable association” between a child’s emotional development and their parent’s breast cancer diagnosis or treatment.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
Image of two doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Related Content
Advertisement
Patti McGee is an author, a massage therapist and breast cancer survivor of 20 years. Catch up on all of Patti's blogs here!
August 2nd 2025

Building My Medical Team and Support System After a Cancer Diagnosis

Patti McGee
After my cancer diagnosis, I built a strong medical team and support system that helped me heal; reaching out and accepting help made all the difference.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
August 2nd 2025

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Bonnie Annis is a breast cancer survivor, diagnosed in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Catch up on all of Bonnie's blogs here!
August 2nd 2025

True Life Stories About Cancer Can Inspire Others

Bonnie Annis
Watching a true-life story about a woman’s battle with cancer has given me a new perspective on life.
Cancer Horizons podcast logo
August 2nd 2025

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of Woman.
August 2nd 2025

My Passion for Guiding Women With Cancer to Embracing the ‘New You’

Patti McGee
Cancer changed my life and inspired me to guide other women in healing, self-love and rediscovering their strength through massage and coaching.
Gedatolisib combo improved PFS in patients with advanced breast cancer after prior therapies: © stock.adobe.com.
August 2nd 2025

Gedatolisib Triplet Boosts Progression-Free Survival in Breast Cancer

Spencer Feldman
Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer after prior therapies.
Related Content
Advertisement
Patti McGee is an author, a massage therapist and breast cancer survivor of 20 years. Catch up on all of Patti's blogs here!
August 2nd 2025

Building My Medical Team and Support System After a Cancer Diagnosis

Patti McGee
After my cancer diagnosis, I built a strong medical team and support system that helped me heal; reaching out and accepting help made all the difference.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
August 2nd 2025

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
Bonnie Annis is a breast cancer survivor, diagnosed in 2014 with stage 2b invasive ductal carcinoma with metastasis to the lymph nodes. Catch up on all of Bonnie's blogs here!
August 2nd 2025

True Life Stories About Cancer Can Inspire Others

Bonnie Annis
Watching a true-life story about a woman’s battle with cancer has given me a new perspective on life.
Cancer Horizons podcast logo
August 2nd 2025

Conference Highlights from SABCS

Alex Biese Brielle Benyon
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Image of Woman.
August 2nd 2025

My Passion for Guiding Women With Cancer to Embracing the ‘New You’

Patti McGee
Cancer changed my life and inspired me to guide other women in healing, self-love and rediscovering their strength through massage and coaching.
Gedatolisib combo improved PFS in patients with advanced breast cancer after prior therapies: © stock.adobe.com.
August 2nd 2025

Gedatolisib Triplet Boosts Progression-Free Survival in Breast Cancer

Spencer Feldman
Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer after prior therapies.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.